Skip to content

Clinical trials

Completed Phase 3 Heart Failure trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Status: Completed Clear all

185 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20017
20029
200312
20045
200510
200611
200714
20087
20096
20104
20114
20128
20135
20148
20153
20168
20179
20187
20197
202010
20215
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed185

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)10
AstraZeneca9
Novartis Pharmaceuticals9
Duke University7
Scios, Inc.7
Boehringer Ingelheim6
Janssen Research & Development, LLC3
LivaNova3
NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)3
Otsuka Pharmaceutical Co., Ltd.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure185
Cardiovascular Diseases17
Heart Diseases17
Myocardial Infarction15
Renal Insufficiency13
Cardiomyopathies11
Hypertension9
Atrial Fibrillation5
Stroke5
Arrhythmias, Cardiac4

Trials

Showing 1 to 25 of 185. Each trial links to its page on Pharma Observatory.

85 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.